Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4331389 | 4122132 | I | 4331389-X | 20031201 | 20040318 | 20040331 | EXP | 2004018561 | WWS PFIZER INC | 22 | YR | M | N | 20040330 | OT |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4331389 | 1004759743 | PS | ZITHROMAX | 1 | ORAL | 750 MG (WEEKLY), ORAL | U | U | 50670 | ||
| 4331389 | 1004772215 | SS | ITRACONAZOLE | 1 | ORAL | 300 MG (DAILY), ORAL | U | U | |||
| 4331389 | 1004772217 | C | PANCREATIN TRIPLE STRENGTH CAP | 1 | |||||||
| 4331389 | 1004772218 | C | URSODEOXYCHOLIC ACID (URSODEOXYCHOLIC ACID) | 2 | |||||||
| 4331389 | 1004772221 | C | TOCOPHEROL CONCENTRATE CAP | 1 | |||||||
| 4331389 | 1004772225 | C | MULTIVITAMIN | 1 | |||||||
| 4331389 | 1004772227 | C | TEICOPLANIN (TEICOPLANIN) | 2 | |||||||
| 4331389 | 1004772228 | C | FERROUS SULFATE TAB | 1 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 4331389 | 1004759743 | ILL-DEFINED DISORDER |
| 4331389 | 1004772215 | ILL-DEFINED DISORDER |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 4331389 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 4331389 | PERICARDIAL EFFUSION |
| 4331389 | PERICARDITIS |
| 4331389 | RESPIRATORY FAILURE |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 4331389 | FGN |
| 4331389 | HP |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 4331389 | 1004759743 | 20040210 | |||
| 4331389 | 1004772215 | 20040210 |